Literature DB >> 20299954

Casp8p41 expression in primary T cells induces a proinflammatory response.

Julie A Taylor1, Nathan W Cummins, Gary D Bren, Stacey A Rizza, Christopher P Kolbert, Marshall D Behrens, Keith L Knutson, Jane C Kahl, Yan W Asmann, Andrew D Badley.   

Abstract

OBJECTIVE: HIV infection of CD4 T cells can lead to HIV protease-mediated cleavage of procaspase 8 generating a novel, HIV-specific peptide called Casp8p41. Casp8p41 has at least two biologic functions: induction of cell death via mitochondrial depolarization and release of cytochrome C, as well as activation of nuclear factor kappa B (NFkappaB). We have previously shown that Casp8p41-induced NFkappaB activation enhances HIV LTR transcription and consequently increases HIV replication. Herein, we questioned whether Casp8p41-induced NFkappaB activation impacts the cytokine profile of cells expressing Casp8p41.
DESIGN: Analysis of cells expressing Casp8p41 and HIV-infected T cells.
METHODS: We assessed whether host genes are transcriptionally activated following Casp8p41 production, using microarray analysis, cytokine quantification, followed by western blot and flow cytometry.
RESULTS: Microarray analysis identified 259 genes significantly upregulated following expression of Casp8p41. Furthermore, Casp8p41 expression in primary CD4 T cells results in increased production of interleukin (IL)-2, IL-15 and tumor necrosis factor (TNF), as well as IL-1RA; whereas levels of granulocyte macrophage colony-stimulating factor and interferon (IFN)-gamma were reduced in the Casp8p41 expressing cells. Intracellular flow cytometry confirmed the co-association of Casp8p41 with elevated TNF in HIV-infected cells.
CONCLUSION: These data indicate that the expression of Casp8p41 in HIV-infected CD4 T cells in addition to promoting apoptosis and enhancing HIV replication also promotes a proinflammatory cytokine milieu, which is characteristic of untreated HIV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299954      PMCID: PMC3150465          DOI: 10.1097/QAD.0b013e3283389e90

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  15 in total

1.  Faster cyclic loess: normalizing RNA arrays via linear models.

Authors:  Karla V Ballman; Diane E Grill; Ann L Oberg; Terry M Therneau
Journal:  Bioinformatics       Date:  2004-05-27       Impact factor: 6.937

2.  Interleukin-2 production by persons with the generalized lymphadenopathy syndrome or the acquired immune deficiency syndrome.

Authors:  C H Kirkpatrick; K C Davis; C R Horsburgh; D L Cohn; K Penley; F N Judson
Journal:  J Clin Immunol       Date:  1985-01       Impact factor: 8.317

3.  Tumor necrosis factor and HIV P24 antigen levels in serum of HIV-infected populations.

Authors:  M M Reddy; S J Sorrell; M Lange; M H Grieco
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1988

4.  Characterization of immunologic function in homosexual men with persistent, generalized lymphadenopathy and acquired immune deficiency syndrome.

Authors:  R L Burkes; W Abo; A M Levine; M Linker-Israeli; J W Parker; P S Gill; M Krailo; D A Horwitz
Journal:  Cancer       Date:  1987-02-15       Impact factor: 6.860

5.  Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo.

Authors:  Zilin Nie; Gary D Bren; Stacey R Vlahakis; Alicia Algeciras Schimnich; Jason M Brenchley; Sergey A Trushin; Sarah Warren; David J Schnepple; Colin M Kovacs; Mona R Loutfy; Daniel C Douek; Andrew D Badley
Journal:  J Virol       Date:  2007-04-18       Impact factor: 5.103

Review 6.  Cytokines and HIV-1: interactions and clinical implications.

Authors:  K Kedzierska; S M Crowe
Journal:  Antivir Chem Chemother       Date:  2001-05

7.  The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappaB activation.

Authors:  Alexander Golks; Dirk Brenner; Peter H Krammer; Inna N Lavrik
Journal:  J Exp Med       Date:  2006-05-08       Impact factor: 14.307

8.  Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication.

Authors:  Gary D Bren; Joe Whitman; Nathan Cummins; Brett Shepard; Stacey A Rizza; Sergey A Trushin; Andrew D Badley
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

9.  Analysis of HIV Protease Killing Through Caspase 8 Reveals a Novel Interaction Between Caspase 8 and Mitochondria.

Authors:  Alicia Algeciras-Schimnich; Anne-Sophie Belzacq-Casagrande; Gary D Bren; Zilin Nie; Julie A Taylor; Stacey A Rizza; Catherine Brenner; Andrew D Badley
Journal:  Open Virol J       Date:  2007-12-27

10.  HIV Protease Cleavage of Procaspase 8 is Necessary for Death of HIV-Infected Cells.

Authors:  Zilin Nie; Gary D Bren; Stacey A Rizza; Andrew D Badley
Journal:  Open Virol J       Date:  2008
View more
  5 in total

1.  The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak.

Authors:  Amy M Sainski; Sekar Natesampillai; Nathan W Cummins; Gary D Bren; Julie Taylor; Dyana T Saenz; Eric M Poeschla; Andrew D Badley
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

2.  Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41.

Authors:  Nathan W Cummins; Jacqueline Neuhaus; Amy M Sainski; Michael A Strausbauch; Peter J Wettstein; Sharon R Lewin; Montserrat Plana; Stacey A Rizza; Zelalem Temesgen; Giota Touloumi; Matthew Freiberg; James Neaton; Andrew D Badley
Journal:  AIDS Res Hum Retroviruses       Date:  2014-02-14       Impact factor: 2.205

Review 3.  Making sense of how HIV kills infected CD4 T cells: implications for HIV cure.

Authors:  Nathan W Cummins; Andrew D Badley
Journal:  Mol Cell Ther       Date:  2014-07-03

Review 4.  Casp8p41: The Protean Mediator of Death in CD4 T-cells that Replicate HIV.

Authors:  Rahul Sampath; Nathan W Cummins; Andrew D Badley
Journal:  J Cell Death       Date:  2016-09-27

5.  Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial.

Authors:  Alessandro Cozzi-Lepri; Martyn A French; John Baxter; Pablo Okhuysen; Montserrat Plana; Jacqueline Neuhaus; Alan Landay
Journal:  AIDS       Date:  2011-06-01       Impact factor: 4.177

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.